The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: A functional urodynamic study in healthy women

European Urology

Volumn 46, Issue 2, 2004, Pages 235-240

  Reitz, André ^a   Haferkamp, Axel ^b   Kyburz, Tatiana ^a   Knapp, Peter A ^a   Wefer, Björn ^a   Schurch, Brigitte ^a  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Muscle relaxation; Tamsulosin; Urethra

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TAMSULOSIN;

ADULT; ARTICLE; BLADDER SPHINCTER; BLOOD PRESSURE; CLINICAL TRIAL; ELECTROLYTE URINE LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; MAGNETIC STIMULATION; MEASUREMENT; MONITORING; MUSCLE CONTRACTION; MUSCLE TONE; NORMAL HUMAN; PELVIS FLOOR; PRESSURE TRANSDUCER; PRIORITY JOURNAL; SPINAL ROOT; URINE RETENTION; URODYNAMICS;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; ELECTROMAGNETICS; FEMALE; HUMANS; LUMBOSACRAL PLEXUS; MUSCLE CONTRACTION; PHYSICAL STIMULATION; SULFONAMIDES; URETHRA; URODYNAMICS;

EID: 3142526420     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.04.009     Document Type: Article

References (28)

1. Fowler C.J., Christmas T.J., Chapple C.R., Parkhouse H.F., Kirby R.S., Jacobs H.S. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ. 297(6661):1988;1436-1438
2. Fowler C.J., Kirby R.S. Electromyography of urethral sphincter in women with urinary retention. Lancet. 1(8496):1986;1455-1457
3. Swinn M.J., Kitchen N.D., Goodwin R.J., Fowler C.J. Sacral neuromodulation for women with Fowler's syndrome. Eur. Urol. 38(4):2000;439-443
4. Phelan M.W., Franks M., Somogyi G.T., Yokoyama T., Fraser M.O., Lavelle J.P., et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J. Urol. 165(4):2001;1107-1110
5. Fowler C.J., Betts C.D., Christmas T.J., Swash M., Fowler C.G., Kirby R.S. Botulinum toxin in the treatment of chronic urinary retention in women. Br. J. Urol. 70(4):1992;387-389
6. Kumar A., Mandhani A., Gogoi S., Srivastava A. Management of functional bladder neck obstruction in women: use of alpha-blockers and pediatric resectoscope for bladder neck incision. J. Urol. 162(6):1999;2061-2065
7. Kihara K., de Groat W.C. Sympathetic efferent pathways projecting to the bladder neck and proximal urethra in the rat. J. Auton. Nerv. Syst. 62(3):1997;134-142
8. Andersson K.E. Pharmacology of the lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev. 45(3):1993;253-308
9. Danuser H., Bemis K., Thor K.B. Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat. Inhibition of central sympathetic and somatic outflow to the lower urinary tract of the cat by the alpha 1 adrenergic receptor antagonist prazosin. J. Pharmacol. Exp. Ther. 274(2):1995;820-825
10. Danuser H., Thor K.B. Inhibition of central sympathetic and somatic outflow to the lower urinary tract of the cat by the alpha 1 adrenergic receptor antagonist prazosin. J. Urol. 153(4):1995;1308-1312
11. Testa R., Guarneri L., Ibba M., Strada G., Poggesi E., Taddei C., et al. Characterization of alpha 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur. J. Pharmacol. 249(3):1993;307-315
12. Yablonsky F., Riffaud J.P., Lacolle J.Y., Dausse J.P. Alpha 1- and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. Eur. J. Pharmacol. 121(1):1986;1-8
13. Ahmed H., Moriyama N., Fukasawa R., Nishimatsu H., Tanaka Y., Kitamura T., et al. Contractile properties of urethral smooth muscles of young and aged female dogs: morphological and pharmacological aspects. Int. J. Urol. 7(8):2000;298-306
14. Alberts P., Bergstrom P.A., Fredrickson M.G. Characterisation of the functional alpha-adrenoceptor subtype in the isolated female pig urethra. Eur. J. Pharmacol. 371(1):1999;31-38
15. Nasu K., Moriyama N., Fukasawa R., Tsujimoto G., Tanaka T., Yano J., et al. Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra. Br. J. Pharmacol. 123(7):1998;1289-1293
16. Taki N., Taniguchi T., Okada K., Moriyama N., Muramatsu I. Evidence for predominant mediation of alpha1-adrenoceptor in the tonus of entire urethra of women. J. Urol. 162(5):1999;1829-1832
17. Thind P., Lose G., Colstrup H., Andersson K.E. The effect of alpha-adrenoceptor stimulation and blockade on the static urethral sphincter function in healthy females. Scand. J. Urol. Nephrol. 26(3):1992;219-225
18. Caine M., Pfau A., Perlberg S. The use of alpha-adrenergic blockers in benign prostatic obstruction. Br. J. Urol. 48(4):1976;255-263
19. Foglar R., Shibata K., Horie K., Hirasawa A., Tsujimoto G. Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur. J. Pharmacol. 288(2):1995;201-207
20. Michel M.C., Grubbel B., Taguchi K., Verfurth F., Otto T., Kropfl D. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J. Auton. Pharmacol. 16(1):1996;21-28
21. Yamada S., Suzuki M., Tanaka C., Mori R., Kimura R., Inagaki O., et al. Comparative study on alpha 1-adrenoceptor antagonist binding in human prostate and aorta. Clin. Exp. Pharmacol. Physiol. 21(5):1994;405-411
22. Andersson K.E. The concept of uroselectivity. Eur. Urol. 33(Suppl 2):1998;7-11
23. Chapple C., Andersson K.E. Tamsulosin: an overview. World J. Urol. 19(6):2002;397-404
24. Abrams P., Schulman C.C., Vaage S. Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group. Br. J. Urol. 76(3):1995;325-336
25. Abrams P., Speakman M., Stott M., Arkell D., Pocock R. A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia). Br. J. Urol. 80(4):1997;587-596
26. Lepor H. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group. Urology. 51(6):1998;901-906
27. Abrams P., Amarenco G., Bakke A., Buczynski A., Castro-Diaz D., Harrison S., et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J. Urol. 170(4 Pt 1):2003;1242-1251
28. Kakizaki H., Ameda K., Kobayashi S., Tanaka H., Shibata T., Koyanagi T. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder. Int. J. Urol. 10(11):2003;576-581